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ABSTRACT  
Background: 
Esophageal pressure topography (EPT) diagnosis of Ineffective Esophageal Motility 
(IEM) can be nonspecific with unclear clinical significance.  
Aims: 
To determine whether peristaltic vigor or lower esophageal sphincter (LES) integrity is 
associated with poor clearance and acid reflux in IEM.  
Methods: 
Bolus clearance on High-resolution impedance manometry (HRIM) and available reflux 
studies in patients with IEM were retrospectively reviewed. Bolus clearance was 
assessed using both line tracing and colored contour methods on HRIM. EPT 
parameters, bolus clearance, and acid reflux variables were explored. 
Key Results: 
Eighty-eight patients with IEM were included.  Bolus clearance occurred in 71% of all 
swallows, and 55.7% of patients had complete bolus transit (CBT, bolus clearance in 
≥80% of swallows). Bolus clearance was impaired in swallows with Distal Contractile 
Integral (DCI) <100mmHg-s-cm compared to DCI 100-450 (0.43 vs 0.79, p<0.0001). A 
cutoff at DCI 100mmHg-s-cm was associated with clearance with an accuracy of 76% 
compared to 49% at DCI 450 (p=0.0001 for both). A median DCI <100 was associated 
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with a higher Eckardt score (9 vs 3, p=0.03), and on reflux testing available in 47 
patients, with abnormal acid exposure time (p=0.002). Peristaltic reserve (PR) defined 
as (DCI of Multiple Rapid Swallow/ median DCI of wet swallows), Integrated Relaxation 
Pressure, and resting Lower Esophageal Sphincter pressure were not associated with 
clearance or acid exposure.  
Conclusions and Inferences: 
Failed peristalsis, as defined by DCI <100mmHg-s-cm, is associated with impaired 
bolus clearance and more severe dysphagia in IEM, and likely abnormal acid exposure.  
 
Abbreviations: AET: Acid-exposure Time, AUC: Area-under-the-curve, BFT: Bolus Flow 
Time, CBT: Complete Bolus Transit, DCI: Distal Contractile Integral, EGJOO: 
Esophagogastric Junction Outflow Obstruction, EII: Esophageal Impedance Integral, 
EPT: Esophageal Pressure Topography, FC: Functional Clearance, HRM: High-
resolution Manometry, HRIM: High-resolution Impedance Manometry, IRB: Institutional 
review board, IRP: Integrated Relaxation Pressure, LES: Lower Esophageal Sphincter, 
PFA: Pressure-flow-analysis, PPI: Proton-pump inhibitor, PR: Peristaltic reserve, ROC: 
Receiver Operating Characteristic  
 
KEY POINTS • Ineffective esophageal motility (IEM) is an esophageal motility disorder with 
unclear clinical implications. We aim to determine whether strength of peristalsis, 
peristaltic reserve or lower esophageal sphincter integrity predicts symptoms or 
clinical outcomes. • We found that a Distal Contractile Integral (DCI) of <100 mmHg-s-cm is 
associated with impaired bolus clearance and a higher degree of dysphagia in 
IEM. • Treatment of IEM should be conservative when DCI is >100 mmHg-s-cm. More 
aggressive treatment of present reflux disease and prokinetic agents may be 
indicated when DCI is <100.   
 
INTRODUCTION 
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Ineffective esophageal motility (IEM), a nonspecific or minor motility disorder 
characterized by a combination of weak and failed peristalsis, is a frequent esophageal 
manometric finding oftentimes with unclear clinical significance.  With the implication of 
poor esophageal emptying, IEM has been associated with prolonged acid exposure and 
peptic complications (1, 2), as well as symptomatic nonobstructive dysphagia 3( ).  The 
definition of IEM has evolved over time.  In the conventional line tracing (CLT) era, IEM 
was defined as low-amplitude (<30 mmHg) distal esophageal contractions in 50% or 
more wet swallows.  Using this definition, studies have found impaired liquid bolus 
transit in up to ~70% of patients with IEM 4-6( ), and the association of IEM with 
gastroesophageal reflux disease had been assessed 7( , 8).  Since the introduction of 
high-resolution manometry (HRM), the CLT definition of IEM was initially translated in 
esophageal pressure topography (EPT) as weak peristalsis with small and large 
peristaltic defects or frequently (>30%) failed peristalsis, then more recently as 50% or 
more swallows with a Distal Contractile Integral (DCI) less than 450 mmHg-s-cm 9( )
IEM is the most common manometric abnormality (up to 20-30%)
.  An 
evaluation of bolus transit in the current EPT diagnosis of IEM has not been conducted.  
Furthermore, correlation of impaired bolus transit in IEM with symptoms and distal 
esophageal acid exposure has not been evaluated.  
(5); yet a 
standard clinical approach for this diagnosis does not exist. Moreover, the clinical 
relevance and benefit of treating IEM is unclear for several reasons.  Many patients with 
this manometric finding are asymptomatic; and those symptomatic have variable 
complaints including dysphagia, cough, or reflux symptoms 10( ).  Management of IEM is 
challenging as the impact of weakened peristaltic vigor on symptoms is uncertain, and 
prior studies have associated minor esophageal motor abnormalities with good long-
term prognosis even with minimal intervention 11( ).  There is currently no therapeutic 
intervention that reliably restores smooth muscle contractility in patients with IEM. Use 
of bethanechol, a muscarinic receptor agonist shown to be effective in improving 
esophageal contraction in small case series of IEM patients, has been limited by side 
effects of dizziness, headaches, nausea, and vomiting, that frequently outweigh 
potential clinical benefits 12( , 13). In IEM patients with refractory reflux, tailored 
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fundoplication is sometimes employed as the management strategy; however, this 
approach has not been shown to be beneficial (14)
The most recent iteration of the Chicago Classification v3.0 has retained its 
definition of IEM as a minor motility disorder 
.   
(15) where the clinical significance of the 
condition continues to be actively debated.  There has been significant interest in 
phenotyping IEM based on the degree of peristaltic impairment and using Multiple 
Rapid Swallows (MRS) to characterize Peristaltic Reserve (PR), the DCI ratio after MRS 
/ median DCI of the 10 swallows 16-19( )
 
. The aim of our study was to determine whether 
the degree of impairment in peristaltic vigor, as measured by DCI and PR, or lower 
esophageal sphincter integrity is associated with poor clearance and acid reflux in IEM.  
We set out to determine the parameter and its threshold value that would help identify 
the subpopulation of IEM patients with poor bolus transit. 
MATERIALS AND METHODS 
 
Study design 
This was a cross-sectional retrospective cohort study. Consecutive high-
resolution impedance manometry (HRIM) procedures performed in adult patients (older 
than 18 years of age) in the Gastrointestinal Physiology Lab at the University of 
Michigan between February of 2015 and May of 2016 were screened for the diagnosis 
of weak peristalsis, frequently failed peristalsis, and IEM. HRIM tracings for included 
patients were reviewed again to confirm an accurate diagnosis of IEM per Chicago 
Classification v3.0.  Study protocol was approved by the Institutional Review Board 
(IRB) at the University of Michigan.   
 
Review of medical record 
The electronic medical records of included subjects were reviewed. Data 
obtained included demographic information, medical and surgical history, medications, 
diagnostic testing such as endoscopy, barium esophagram, and pH testing, esophageal 
symptoms, and patient reported outcome (PRO) questionnaires which included Eckardt, 
Brief Esophageal Dysphagia Questionnaire (BEDQ) and GERDQ (20-22).  
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Manometry and Intraluminal Impedance measurement 
Patients underwent manometry using a combined High-resolution manometry 
and intraluminal impedance (HRIM) system. This is a solid-state assembly with 36 
levels of pressure sensors and 12 impedance-sensing segments (Medtronic, Dublin, 
Ireland).  The response characteristics of this device, calibration procedure, and post-
study thermal correction algorithm have been described in detail previously (23)
 
.  Briefly, 
the HRIM assembly was passed transnasally and positioned to record from the 
hypopharynx to the stomach with about 5 intragastric sensors.  The manometric 
protocol included a 5-minute period for acclimatization and to assess basal sphincter 
pressure followed by ten 5ml liquid swallows of 0.45% saline in the supine position.  In 
most studies an additional MRS sequence involving five 2ml swallows every 2-3 
seconds was performed in the upright position.  The combined pressure-impedance 
data were manually analyzed using the ManoView ESO v.3.0.1 software (Medtronic).  
After thermal compensation, the HRM studies were manually analyzed in accordance 
with the Chicago Classification v3.0.  After confirming the diagnosis of IEM, data for 
individual swallows were extracted by documenting the values for each parameter: 
basal lower esophageal sphincter (LES) pressure, distance between LES-crural 
diaphragm (LES-CD), Integrated Relaxation Pressure (IRP), and Distal Contractile 
Integral (DCI). DCI after Multiple Rapid Swallows (MRS) was also recorded.  Then the 
color isobaric contour plots were overlaid with impedance line tracings by selecting the 
“enabling impedance trace on contour” option.  The display mode button was changed 
to impedance tracing on contour (colored contour and lines).  Included studies were re-
analyzed retrospectively by a single primary reader blinded to the clinical profile. Bolus 
transit was assessed via line-tracing and contour methods as below.  A second reader 
blindly reviewed 22 (25%) randomly selected studies for comparison. 
Bolus clearance 
Complete Bolus Transit 
Bolus transit was assessed for each swallow using impedance line tracings. 
Bolus entry was defined as a >50% drop in impedance level from baseline at the 
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proximal recording site; and complete bolus transit (CBT) was defined as a >50% drop 
from baseline followed by an increase back to at least 50% from impedance nadir at the 
three distal recording sites following bolus entry (3)
 
.  In instances where the impedance 
baseline before each swallow was low indicating retained bolus pre-swallow, impedance 
baseline during the “landmark-ID” measurement period was used as the reference 
impedance level to assess bolus transit.  Each of the 10 wet swallows was scored as 
either complete or incomplete bolus clearance.  Examples of complete and incomplete 
bolus transit are shown in Figure 1.  
Functional Clearance 
Bolus clearance was also assessed via colored contour method.  Impedance 
data were displayed as a monochrome color gradient overlaying the pressure 
topography by changing the contour mode.  The color contrast, manually adjustable by 
changing the level of impedance indication in kOhm, was adjusted so that the contour 
showed an emptying esophagus before initiation of the 0.45% saline swallow sequence, 
and the liquid ingested with each swallow was just visible.  Bolus clearance was defined 
by the absence of bolus in the distal esophagus after each swallow.  Incomplete 
functional clearance (FC) was defined as evidence of residual fluid bolus in the distal 
esophagus.  
 
24-hour Multichannel Intraluminal Impedance-pH (MII-pH) Monitoring 
The combined pH-impedance assembly (Sandhill Scientific, Highlands Ranch, 
CO) was positioned with the proximal pH electrode 5 cm above the manometrically 
identified lower esophageal sphincter (LES). Impedance was measured 3, 5, 7, 9, 15, 
and 17 cm above the LES.  Event markers recorded occurrence of symptoms, meals, 
and changes in posture.  The recorded data was analyzed in accordance with 
previously published criteria (24).  Total percent time pH < 4, or the acid exposure time 
(AET), was chosen as the primary reflux parameter.  Active proton-pump inhibitor (PPI) 
usage and dosing was noted.  An AET of > 4.2% off PPI, and an AET of > 1.6% on PPI 
were considered abnormal 25( ). All MII-pH studies were performed on the same day as 
HRIM or within 4 months afterwards. 
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Statistical methods 
CBT and FC were determined for each of 10 supine swallows. Agreement 
between CBT and FC was calculated across all supine swallows.  CBT frequency was 
calculated in swallows in distinct DCI subgroups.  Receiver-operating characteristic 
(ROC) curve was constructed for CBT based on DCI for all swallows. ROC curves for 
complete bolus transit defined as CBT in 80% or more of 10 supine swallows were 
constructed based on % ineffective swallows and % failed swallows (5)
 
. Cutoff values for 
ROC curves were selected using Youden’s index.  Logistic regression analysis was 
performed to evaluate associations between CBT and AET with the following variables 
as relevant: IRP, resting LES pressure, PR, median DCI, mean DCI. Correlation 
between elevated AET and DCI at our chosen cutoff was assessed. Parametric 
variables were compared using unpaired t-test. Non-parametric variables were 
compared using Mann-Whitney test.  Categorical variables were analyzed using chi-
square or Fisher’s exact test.  A p-value of 0.05 was considered statistically significant 
for all analyses.  On ROC curves, an area under the curve (AUC) greater than 0.70 was 
deemed sufficient for categorical analysis. 
RESULTS 
Sample description 
Eighty-eight adult patients with a confirmed EPT diagnosis of IEM were included 
in this analysis.  Eighty-seven of these studies were originally diagnosed using Chicago 
Classification V3.0 criteria; one study was re-classified from frequent failed peristalsis 
on V2.0 to IEM. Seventy-five patients had available multiple rapid swallows.  Ten 
patients with IEM had a history of prior fundoplication.  Forty-seven patients had 
available MII-pH testing after excluding patients with prior fundoplication.  Sixteen of 
these studies were performed on patients off PPI therapy, and the remaining 31 studies 
were performed in patients on PPI therapy. 
Demographics and relevant clinical data are displayed in Table 1.  Mean age in 
our IEM group was 53.1 (SD 16.5); female: male ratio was 1.6. In addition to the 10 
patients with prior fundoplication, 1 patient each with prior Roux-en-Y gastric bypass 
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(RNYGB) and sleeve gastrectomy were included.  One patient with eosinophilic 
esophagitis and 3 patients with scleroderma were included.  The indications for 
manometry were dysphagia (44%), GERD (37%), nausea (6%), cough (3%), pre-lung 
transplant evaluation (3%), chest pain (2%), dyspnea (2%), globus (1%), and abdominal 
pain (1%). A breakdown of all symptoms in the IEM group is shown in Table 2. Reflux-
like symptoms including heartburn and/or regurgitation were the most prevalent 
symptoms in 60.2% of patients, followed by dysphagia in 45.5%, abdominal pain in 
26.1%, and nausea in 23.9%.  Seventy-nine % of patients with heartburn and/or 
regurgitation were on a PPI; 82.5% of patients with dysphagia were on a PPI. 
Prevalence of certain medication classes prescribed to IEM patients are also shown in 
Table 2. Opioids were prescribed in 20.4% of patients. Esophageal testing data is 
shown in Table 3. Dysmotility on esophagram was seen in 61.4%, gastroesophageal 
reflux in 52.6%.  Erosive esophagitis or Barrett’s was noted in 26.2% of upper 
endoscopies. Hiatal hernia was noted on manometry in 29.5%.   
 
Bolus Transit 
Proportion of CBT and FC in 880 swallows in IEM patients were 0.71 and 0.73 
respectively, with a kappa value of 0.83, indicating excellent agreement between the 
two methods to assess bolus transit on HRIM.  The ROC curve for CBT according to 
DCI is shown in Figure 2.  The Area Under the Curve (AUC) was 0.77.  A DCI of less 
than 100 mmHg-s-cm had the best accuracy (76%) for impaired bolus transit, and a 
negative predictive value of 83% (p = 0.0001).  A DCI of cutoff of 450 mmHg-s-cm had 
an accuracy of 49% (p = 0.0001).  CBT and FC in DCI subgroups are shown in Figure 
3. The largest step-off was noted between the DCI < 100 (CBT 0.43, FC 0.42) and DCI 
100-249 groups (CBT 0.77, FC 0.78). In the DCI > 450 group, CBT was 0.91 and FC 
was 0.92.  When CBT in each group was compared to the other 3 groups using Mann-
Whitney test, all were statistically significant other than the DCI 100-249 group (p values 
0.0001 – 0.10 as shown in Figure 3).  Agreement with a second reader in 25% of 
randomly selected studies was excellent (k=0.80 for CBT, k=0.83 for FC).  
Complete bolus transit in ≥80% of swallows was observed in 55.7% of patients. 
ROC curves for all ineffective swallows (weak and failed) and failed swallows alone in 
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association with complete bolus transit in 80% or more swallows are in shown in Figure 
4.  AUC for all ineffective swallows was 0.52 whereas for failed swallows only was 0.73.  
Failed swallows ≥ 30% had an accuracy of 72% and a NPV of 80% (p = 0.0001).  On 
logistic regression analysis, mean DCI and median DCI were associated with complete 
bolus transit (p-values 0.04 and 0.05 respectively); however, on individual ROC curve 
analysis, AUCs were low at 0.57 and 0.60 respectively.  DCI after multiple rapid swallow 
(MRS) and the peristaltic reserve (PR = DCI MRS / wet swallows ratio) were not 
associated with complete bolus transit.   
We performed a secondary analysis of CBT in association with DCI across all 
supine swallows, excluding patients with any foregut surgery history (N=76). AUC was 
similar at 0.76, and a DCI of <100 mmHg-s-cm was associated with impaired clearance 
(p = 0.0001) with accuracy of 77% and NPV 84%.  
 
Acid Exposure Time 
With exclusion of patients with prior fundoplasty, 23 of 47 patients (48.9%) had 
an elevated AET.  No associations between mean DCI, median DCI, resting LES, 
median IRP, MRS DCI, or PR and elevated AET were found.  However, on categorical 
analysis, all 8 patients with a median DCI < 100 mmHg-s-cm had an elevated AET (PPV 
100%, accuracy 68.1%, p = 0.002).  When median DCI was > 100 mmHg-s-cm, 25 / 40 
(61.2%) of patients had a normal AET.  
Separating acid exposure by PPI use – 5 of 16 patients (31.3%) off PPI; and 18 
of 31 (58.1%) on PPI had an elevated AET. There were no differences in median DCI, 
CBT or MRS augmentation ratio in association with elevated AET using this grouping. 
However, there appeared to be a trend towards impaired MRS augmentation in the 
elevated AET group off PPI (ratio of 0.1 vs 2.2).  
We performed a separate analysis of the 46 patients without any foregut surgery, 
excluding an additional patient with a prior sleeve gastrectomy. Median DCI <100 
mmHg-s-cm remained associated with an elevated AET in all 8 patients, and 25/39 
(64.1%) of patients with a median DCI >100 mmHg-s-cm had a normal AET. 
 
Patient Reported Outcomes (PRO) 
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PRO questionnaires were collected from a total of 38 patients with IEM at the 
time of HRIM.  These included 38 Eckardt, 36 BEDQ, and 36 completed GERDQ 
surveys.  In patients with available MII-pH testing, 24 Eckardt scores, 22 BEDQ scores, 
and 22 GERDQ surveys were collected.  Median scores for patients with complete and 
incomplete bolus transit, normal and elevated AET, and DCI >100 and <100 mmHg-s-
cm are shown in Figure 5 and Table 4.  There was a trend towards higher scores when 
median DCI was <100, with a statistically significant difference in Eckardt score (9 vs 3, 
p = 0.03).  Although no statistically significant differences were noted with abnormal 
CBT or AET, a trend towards higher BEDQ scores was noted with abnormal CBT and 
elevated AET.  
 
DISCUSSION 
The latest iteration of the Chicago Classification reinstated the diagnosis of 
ineffective esophageal motility, which is now defined as decreased contractile vigor with 
DCI <450 mmHg-s-cm in 50% or more swallows.  This includes a combination of weak 
and failed swallows.  However, the clinical significance of IEM remains unclear. 
Attempts at subtyping IEM based on type of abnormal bolus transit (viscous, liquid, or 
both), and most recently, degree of peristaltic dysfunction (17)
Our study showed that a DCI of less than 100 mmHg-s-cm – the DCI threshold 
used for failed peristalsis – identifies a phenotypically more severe subgroup of IEM 
with decreased bolus clearance, more severe dysphagia, and likely abnormal acid 
exposure. Our results support DCI as the most functionally relevant metric in evaluation 
of IEM, over the IRP or the peristaltic reserve. The most clinically relevant finding is that 
patients with a median DCI of >100 mmHg-s-cm had a normal Eckardt score (median 3) 
in the setting of >80% complete bolus transit, whereas those with a DCI <100 mmHg-s-
cm had a median Eckardt score of 9. Our study is the first to correlate patient reported 
outcomes with HRM metrics in IEM. We feel this difference provides enough evidence 
for conservative management of IEM with DCI >100 mmHg-s-cm. Conversely, it may be 
reasonable to trial procholinergic agents such as bethanechol in patients with a median 
 have been made.  Since 
transition to EPT, no studies have attempted to phenotype IEM using impaired bolus 
transit on intraluminal impedance as the primary indicator of clinicalyl significant IEM. 
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DCI <100 mmHg-s-cm and dysphagia. The clinical implication of our reflux analysis 
results is less certain. However, despite our low number of patients studied off PPI, the 
elevated AET in all of our patients with a median DCI <100 mmHg-s-cm is important. 
This justifies more aggressive lifestyle or medical reflux treatment, or consideration of 
antireflux surgery such as a partial fundoplication, in this group. Our results do not 
clarify the mechanism or reflux or the cause-effect relationship between IEM and GERD 
– our findings do not imply IEM as a cause of GERD; the reverse could be equally true.  
Our study has some limitations.  A major limitation of our study is the fact that we 
included very few (16) patients in our reflux analysis that were off PPI. A large portion of 
patients were only referred for manometry without pH testing. In order to assess a reflux 
outcome, we included patients on-PPI threshold using a threshold of 1.6% for abnormal 
AET based on prior literature. (25, 26) Second, we did not include a control population for 
comparison of bolus transit.  Although the analysis has not been repeated using the 
EPT definition; bolus transit in IEM has been compared extensively to normal 
manometry and more subtle peristaltic abnormalities using CLT and impedance line 
tracings and was thus not an aim of our study 4-6( ).  Third, our HRIM protocol does not 
include viscous swallows, which might improve the sensitivity for detecting abnormal 
bolus transit 27( )
There have been multiple proposed methods of characterizing bolus clearance 
on impedance manometry, including in IEM. Carlson and colleagues found that the 
bolus flow time (BFT) and esophageal impedance integral (EII) correlated with non-
obstructive dysphagia 
.  Fourth, we included patients with prior fundoplication given the 
relevance of IEM in this population, although clearance could arguably be impaired. 
However, we found that impaired lower esophageal sphincter relaxation, possibly 
related to a fundoplication wrap, was not associated with poor bolus clearance.  
Additionally, five of our ten fundoplication patients had incomplete clearance, which is in 
keeping with the rest of our cohort. Finally, we currently do not have long-term clinical 
outcome data to address whether IEM patients with DCI <100mmHg-s-cm results in a 
more unfavorable clinical aftermath.   
(28). Omari and colleagues found that time from nadir impedance 
to peak pressure (TNadImp) and impedance radio (IR) are other useful pressure-flow-
analysis (PFA) metrics for analyzing bolus clearance 29( ). Our goal was to study a 
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universally available method that could be utilized by clinical gastroenterologists. Our 
group recently showed that the conventional line tracing method of evaluating bolus 
transit and colored contour method were useful in measuring bolus transit in achalasia 
and esophagogastric junction outflow obstruction (EGJOO). (30)
In summary, our study shows that 50% or more failed peristalsis in IEM is 
associated with poor bolus clearance and a higher degree of dysphagia. This group of 
severe IEM also likely has elevated acid exposure.  Further outcome analysis and 
therapeutic trials are needed to address the longer-term clinical significance of 
phenotyping IEM and for development of an IEM management guideline.    
. We have now shown 
similar reliability between these two methods in IEM. There may be future utility in 
performing PFA for a more nuanced characterization of bolus transit abnormalities in 
IEM.  
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TABLES 
 
Table 1: Clinical Data (N=88) 
Age (mean) [range] 53.1 [20-83] 
Sex (%)  
     Male 34 (39%) 
     Female 54 (61%) 
Body Mass Index (mean) [SD] 28.1 [5.4] 
Other UGI history (%)  
     Fundoplication 10 (11.3%) 
     RNYGB 1 (1.1%) 
     Sleeve Gastrectomy 1 (1.1%) 
     Eosinophilic Esophagitis 1 (1.1%) 
     Scleroderma 3 (3.4%) 
 
Abbreviations: SD: standard deviation, RNYGB: Roux-en-Y gastric bypass, UGI: upper gastrointestinal 
 
Table 2: HRIM Characteristics by Age and BMI 
Age Number IRP  Basal LES-P DCI % CBT 
     <40 19 4.7 12.7 271.5 63.1% 
     41-60 31 6.2 17 279 45.1% 
     >60 38 6.4 19 257 60.5% 
BMI      
     <25 26 5.9 23.7 276 61.5% 
     25-30 32 4.8 15.3 255 46.8% 
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     >30 23 7.1 16 192 60.8% 
 
Abbreviations: BMI: Body Mass Index, CBT: Complete Bolus Transit, DCI: Distal Contractile Integral, 
HRIM (High-resolution Impedance Manometry, IRP: Integrated Relaxation Pressure, LES-P: Lower 
Esophageal Sphincter Pressure 
 
Table 3: Symptoms and Medication Use (N=88) 
Symptom % of patients  
     Heartburn and/or regurgitation 60.2%   
     Dysphagia 45.5% 
     Abdominal pain 26.1% 
     Nausea 23.9% 
     Cough 17.0% 
Class of Medication % of patients 
     Opioids 20.4% 
     Calcium channel blockers 8.0% 
     Muscle relaxants 6.8% 
     Tricyclic antidepressants 6.8% 
     Nitrates 3.4% 
 
 
Table 4: Esophageal Diagnostic Testing 
Esophagram (N=57)  
     Dysmotility 35 (61.4%) 
     Reflux 30 (52.6%) 
     Hiatal hernia 24 (42.1%) 
     Normal  5 (8.8%) 
Upper Endoscopy (N=72)  
     Erosive esophagitis 11 (15.2%) 
     Barrett’s   8 (11.0%) 
pH testing (N=47)  
     Off PPI therapy (%) 16 (34%) 
          Elevated AET (%)  5 (31.3%) 
     On PPI therapy (%) 31 (66%) 
          Elevated AET (%) 18 (58.1%) 
     Elevated AET overall (%) 23 (48.9%) 
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HRIM (N=88)  
     Complete Bolus Transit 49 (55.7%) 
     LES-CD ≥ 2 cm 26 (29.5%) 
     DCI (mmHg-s-cm)  
          Mean [SD] 341 [218] 
          Median [range] 218 [21-1035] 
     IRP (mmHg)  
          Mean [SD] 6.0 [3.8] 
          Median [range] 5.9 [0.9-13.1] 
     Basal LES pressure (mmHg)  
          Mean [SD] 19.7 [11.6] 
          Median [range] 17.5 [4.8-41] 
 
Abbreviations: AET: Acid-exposure Time, CD: Crural Diaphragm, DCI: Distal Contractile Integral, HRIM: 
High-resolution Impedance Manometry, IRP: Integrated Relaxation Pressure, LES: Lower Esophageal 
Sphincter, PPI: proton-pump inhibitor, SD: standard deviation 
 
 
Table 5: Patient Reported Outcomes 
 Eckardt  BEDQ  GERDQ  
 Median [IQR] P value Median [IQR] P value Median [IQR] P value  
CBT 4 [2-6] 
0.36 
6 [2.5-15] 
0.15 
6 [6-11.5] 
0.98 
No CBT 3 [2-5] 12 [5-25] 7 [6-11] 
AET nl 3 [2-4] 
0.99 
4 [0-10] 
0.19 
7 [6-10] 
0.80 
AET elev 3 [2-5] 8 [4-12] 7 6-12] 
DCI>100 3 [2-5] 
0.03* 
7 [3-14] 0.12 6 [6-10] 
0.16 
DCI<100 9 [3.5-9.5] 25 [10-26]  11 [6.5-12] 
AET nl (off 
PPI) 
4 [2-5] 
 
0.20 
4 [0-14] 
>0.99 
7 [6-13] 
0.33 
AET elev 
(off PPI)  
1.5 [1-2] 3.5 [0-7] 5.5 [5-6] 
AET nl (on 
PPI)  
3 [1-5] 
0.38 
5 [0-10] 
0.11 
6.5 [6-10]  
0.27 
 
AET elev 
(on PPI)  
4 [2-6] 12 [4-25] 8 [6-13] 
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Abbreviations: AET: Acid-exposure Time, BEDQ: Brief Esophageal Dysphagia Questionnaire, CBT: 
Complete Bolus Transit, DCI: Distal Contractile Integral, GERDQ: Gastro-esophageal Reflux Disease 
Questionnaire, IQR: interquartile range 
 
 
 
 
FIGURE LEGENDS: 
 
Figure 1: High-resolution Impedance Manometry (HRIM) depictions of bolus clearance in Ineffective 
Esophageal Motility. Conventional Impedance line tracings are superimposed on HRIM plots with colored 
impedance contour. Panel A shows an example of Complete bolus transit; Panel B shows an example of 
incomplete clearance.  
 
Figure 2: Receiver-operating-characteristic curve of complete bolus transit (CBT) in association with 
Distal Contractile Integral (DCI) in all supine swallows.  
AUC: Area-under-the-curve, NPV: Negative predictive value 
 
Figure 3: Complete bolus transit compared amongst different Distal Contractile Integral (DCI) groups in 
Ineffective Esophageal Motility. Lines indicate comparisons to other groups. Asterisks (*) indicate 
presence of and magnitude of statistical significance.  
 
Figure 4: Receiver-operating-characteristic curves showing incomplete clearance in association with 
ineffective swallows (Panel A) and failed swallows only (Panel B).  
AUC: Area-under-the-curve, NPV: Negative predictive value 
 
Figure 5: Box-and-whisker plots showing median scores for Eckardt, Brief Esophageal Dysphagia 
Questionnaire (BEDQ), and Gastroesophageal Reflux Disease Questionnaire (GERDQ) based on 
clearance, Acid-exposure time (AET), and median Distal Contractile Integral (DCI) per patient.  
Asterisk (*) indicates statistical significance. 
CBT: Complete bolus transit 
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